TITRATE (inducTIon for acuTe ulceRATivE Colitis)
- Status
- TERMINATED
- Phase
- PHASE4
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
A Study to Assess Pharmacokinetics of PF-04965842 and Its Metabolites and Effect of Probenecid in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
An Open-label, Intermediate Size, Expanded Access Study of BHV-3000 in the Acute Treatment of Migraine
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study to Characterize Absorption, Distribution, Metabolism and Excretion of 14C PF-06651600 and to Evaluate the Absolute Oral Bioavailability and Fraction Absorbed of PF-06651600.
- Status
- COMPLETED
- Phase
- PHASE1
Real-World Observational Study Of Zavicefta to Characterize Use Patterns
- Status
- COMPLETED
- Phase
- N/A
UK Ibrance Patient Program (IPP) Study
- Status
- COMPLETED
- Phase
- N/A
Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study
- Status
- COMPLETED
- Phase
- PHASE3
REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
- Status
- COMPLETED
- Phase
- N/A
THE EFFECT OF MULTIPLE DOSES OF PF-06835919 ON THE PHARMACOKINETICS OF A SINGLE ORAL MIDAZOLAM DOSE IN HEALTHY PARTICIPANTS
- Status
- COMPLETED
- Phase
- PHASE1
PF-06651600 Taste Study.
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Skin Irritation Potential With PF-06700841 Cream Formulation Using Negative Control in Adult Japanese Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis
- Status
- TERMINATED
- Phase
- PHASE2
Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Lorlatinib in ALK Inhibitor-Treated ALK-Positive NSCLC in China
- Status
- COMPLETED
- Phase
- PHASE2
LORA-PITA IV General Investigation
- Status
- COMPLETED
- Phase
- N/A